SAADI RYAN H. (Chief Executive Officer) received a stock award from TEVOGEN BIO HOLDINGS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/1/2025ACC: 0001062993-25-012333
DirectorOfficer10% Owner· Chief Executive Officer
Since Feb 2024
+8M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
8M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+8M
Price / share
—
Trade value
—
% of position
6.8%
6/27/2025
116.81M→124.81M
Total
Net shares
+8M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/27/2025 | A · Award | +8M | — | — | 6.8% | 116.81M | 124.81M |
| Total | +8M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned193.92K
Total
193.92K indirect193.92K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 193.92K | Indirect |
| Total | 193.92K | 193.92K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported